Cargando…
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
ATIC, SHMT2, and SLC46A1 have essential roles in one-carbon (1-C) transfer. The authors examined whether associations between ovarian carcinoma and 15 variants in these genes are modified by regular multivitamin use, a source of 1-C donors, among Caucasian participants from two US case–control studi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306919/ https://www.ncbi.nlm.nih.gov/pubmed/22461784 http://dx.doi.org/10.3389/fgene.2012.00033 |
_version_ | 1782227253570043904 |
---|---|
author | Kelemen, Linda E. Wang, Qinggang Dinu, Irina Vierkant, Robert A. Tsai, Ya-Yu Cunningham, Julie M. Phelan, Catherine M. Fridley, Brooke L. Amankwah, Ernest K. Iversen, Edwin S. Berchuck, Andrew Schildkraut, Joellen M. Goode, Ellen L. Sellers, Thomas A. |
author_facet | Kelemen, Linda E. Wang, Qinggang Dinu, Irina Vierkant, Robert A. Tsai, Ya-Yu Cunningham, Julie M. Phelan, Catherine M. Fridley, Brooke L. Amankwah, Ernest K. Iversen, Edwin S. Berchuck, Andrew Schildkraut, Joellen M. Goode, Ellen L. Sellers, Thomas A. |
author_sort | Kelemen, Linda E. |
collection | PubMed |
description | ATIC, SHMT2, and SLC46A1 have essential roles in one-carbon (1-C) transfer. The authors examined whether associations between ovarian carcinoma and 15 variants in these genes are modified by regular multivitamin use, a source of 1-C donors, among Caucasian participants from two US case–control studies. Using a phased study design, variant-by-multivitamin interactions were tested, and associations between variants and ovarian carcinoma were reported stratified by multivitamin supplement use. Per-allele risk associations were modified by multivitamin use at six variants among 655 cases and 920 controls (Phase 1). In a larger sample of 968 cases and 1,265 controls (Phases 1 and 2), interactions were significant (P ≤ 0.03) for two variants, particularly among regular multivitamin users: ATIC rs7586969 [odds ratio (OR) = 0.7, 95% confidence interval (CI) = 0.6–0.9] and ATIC rs16853834 (OR = 1.5, 95% CI = 1.1–2.0). The two ATIC single nucleotide polymorphisms (SNPs) did not share the same haplotype; however, the haplotypes they comprised mirrored their SNP risk associations among regular multivitamin supplement users. A multi-variant analysis was also performed by comparing the observed likelihood ratio test statistic from adjusted models with and without the two ATIC variant-by-multivitamin interaction terms with a null distribution of test statistics generated by permuting case status 10,000 times. The corresponding observed P value of 0.001 was more extreme than the permutation-derived P value of 0.009, suggesting rejection of the null hypothesis of no association. In summary, there is little statistical evidence that the 15 variants are independently associated with risk of ovarian carcinoma. However, the statistical interaction of ATIC variants with regular multivitamin intake, when evaluated at both the SNP and gene level, may support these findings as relevant to ovarian health and disease processes. |
format | Online Article Text |
id | pubmed-3306919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33069192012-03-29 Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma Kelemen, Linda E. Wang, Qinggang Dinu, Irina Vierkant, Robert A. Tsai, Ya-Yu Cunningham, Julie M. Phelan, Catherine M. Fridley, Brooke L. Amankwah, Ernest K. Iversen, Edwin S. Berchuck, Andrew Schildkraut, Joellen M. Goode, Ellen L. Sellers, Thomas A. Front Genet Genetics ATIC, SHMT2, and SLC46A1 have essential roles in one-carbon (1-C) transfer. The authors examined whether associations between ovarian carcinoma and 15 variants in these genes are modified by regular multivitamin use, a source of 1-C donors, among Caucasian participants from two US case–control studies. Using a phased study design, variant-by-multivitamin interactions were tested, and associations between variants and ovarian carcinoma were reported stratified by multivitamin supplement use. Per-allele risk associations were modified by multivitamin use at six variants among 655 cases and 920 controls (Phase 1). In a larger sample of 968 cases and 1,265 controls (Phases 1 and 2), interactions were significant (P ≤ 0.03) for two variants, particularly among regular multivitamin users: ATIC rs7586969 [odds ratio (OR) = 0.7, 95% confidence interval (CI) = 0.6–0.9] and ATIC rs16853834 (OR = 1.5, 95% CI = 1.1–2.0). The two ATIC single nucleotide polymorphisms (SNPs) did not share the same haplotype; however, the haplotypes they comprised mirrored their SNP risk associations among regular multivitamin supplement users. A multi-variant analysis was also performed by comparing the observed likelihood ratio test statistic from adjusted models with and without the two ATIC variant-by-multivitamin interaction terms with a null distribution of test statistics generated by permuting case status 10,000 times. The corresponding observed P value of 0.001 was more extreme than the permutation-derived P value of 0.009, suggesting rejection of the null hypothesis of no association. In summary, there is little statistical evidence that the 15 variants are independently associated with risk of ovarian carcinoma. However, the statistical interaction of ATIC variants with regular multivitamin intake, when evaluated at both the SNP and gene level, may support these findings as relevant to ovarian health and disease processes. Frontiers Research Foundation 2012-03-19 /pmc/articles/PMC3306919/ /pubmed/22461784 http://dx.doi.org/10.3389/fgene.2012.00033 Text en Copyright © 2012 Kelemen, Wang, Dinu, Vierkant, Tsai, Cunningham, Phelan, Fridley, Amankwah, Iversen, Berchuck, Schildkraut, Goode and Sellers. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited. |
spellingShingle | Genetics Kelemen, Linda E. Wang, Qinggang Dinu, Irina Vierkant, Robert A. Tsai, Ya-Yu Cunningham, Julie M. Phelan, Catherine M. Fridley, Brooke L. Amankwah, Ernest K. Iversen, Edwin S. Berchuck, Andrew Schildkraut, Joellen M. Goode, Ellen L. Sellers, Thomas A. Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma |
title | Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma |
title_full | Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma |
title_fullStr | Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma |
title_full_unstemmed | Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma |
title_short | Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma |
title_sort | regular multivitamin supplement use, single nucleotide polymorphisms in atic, shmt2, and slc46a1, and risk of ovarian carcinoma |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306919/ https://www.ncbi.nlm.nih.gov/pubmed/22461784 http://dx.doi.org/10.3389/fgene.2012.00033 |
work_keys_str_mv | AT kelemenlindae regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT wangqinggang regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT dinuirina regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT vierkantroberta regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT tsaiyayu regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT cunninghamjuliem regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT phelancatherinem regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT fridleybrookel regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT amankwahernestk regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT iversenedwins regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT berchuckandrew regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT schildkrautjoellenm regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT goodeellenl regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma AT sellersthomasa regularmultivitaminsupplementusesinglenucleotidepolymorphismsinaticshmt2andslc46a1andriskofovariancarcinoma |